Video Library

Results 1 - 10 of 190

  • In this discussion, titled Community Conversations on Cancer: The Good, the Bad and the Rad in Radiotherapy, Michael Dominello, D.O., shares information on radiotherapy and how it is used to treat cancer from a clinical perspective. Community Conversations on Cancer is a series where community members learn more about what scientists at Karmanos Cancer Institute are doing to fight the disease and how it leads to better treatments and care.

     

  • In this discussion, titled Community Conversations on Cancer: The Good, the Bad and the Rad in Radiotherapy, Michael Joiner, M.A., Ph.D., shares information on radiotherapy and how it is used to treat cancer from a biological perspective. Community Conversations on Cancer is a series where community members learn more about what scientists at Karmanos Cancer Institute are doing to fight the disease and how it leads to better treatments and care.

     

  • In this discussion, titled Community Conversations on Cancer: The Good, the Bad and the Rad in Radiotherapy, Jacob Burmeister, Ph.D., DABR, shares information on radiotherapy and how it is used to treat cancer from a physics perspective. Community Conversations on Cancer is a series where community members learn more about what scientists at Karmanos Cancer Institute are doing to fight the disease and how it leads to better treatments and care.

     

  • cancer care, support service

    Karmanos Cancer Institute's All Cancer Symposium 2022 - Part 2

    The Barbara Ann Karmanos Cancer Institute presented its twelfth annual All Cancer Symposium on Saturday, October 15, 2022. Cancer experts talked about the evolution of cancer care compared to treatment in the past.

    The symposium was sponsored by Pfizer, Caris Life Sciences, Seagen, Eisai, Amgen, AstraZeneca, Sobi, Bayer, Janssen, Puma Biotechnology, Sanofi Genzyme, Myovant Sciences, Exelixis and Aveo Oncology.

     

  • cancer care, support service

    Karmanos Cancer Institute's All Cancer Symposium 2022 - Part 1

    The Barbara Ann Karmanos Cancer Institute presented its twelfth annual All Cancer Symposium on Saturday, October 15, 2022. Cancer experts talked about the evolution of cancer care compared to treatment in the past.

    The symposium was sponsored by Pfizer, Caris Life Sciences, Seagen, Eisai, Amgen, AstraZeneca, Sobi, Bayer, Janssen, Puma Biotechnology, Sanofi Genzyme, Myovant Sciences, Exelixis and Aveo Oncology.

     

  • The Karmanos Cancer Institute at The Toledo Clinic Cancer Center in Maumee is a state-of-the-art health care campus that provides outstanding patient-centered care and delivers new life-changing cancer therapies and treatments, within miles for nearby residents. Under this partnership, Karmanos operates the radiation oncology program, advanced cancer care services and clinical trials at the new freestanding cancer center. Together, our joint teams will advance the fight against cancer in Lucas County. The cancer center is a centerpiece of Side Cut Crossings, a 58-acre development off the Anthony Wayne Trail between Ford Street and Monclova Road.

     

  • In this discussion, titled Cancer Health Equity in Asian American/Pacific Islander Populations: Current Knowledge & Future Direction, researchers share data and provide context as to how the history of Asians in America, westernization, cultural factors, structural barriers and lack of awareness contribute to cancer disparities among the AAPI population in the US and in Michigan.

    RESEARCHERS

    Scarlett Lin Gomez, MPH, Ph.D. Professor, Department of Epidemiology and Biostatistics, University of California, San Francisco

    Tsu-Yin Wu, Ph.D. Professor and Ph.D. Program Director, School of Nursing, Eastern Michigan University

    Lauren Spadafora, Ph.D. Cancer Epidemiologist, Michigan Department of Health and Human Services

     

  • Book Focus: "A Review of Research on Disparities in the Care of Black and White Patients With Cancer in Detroit"

     

  • March is Colon Cancer Awareness Month! Did you know that adults at average risk should schedule their first colonoscopy at age 45 and continue every 10 years if the results are normal?

    Learn more about colon screening here.

     

  • cancer care

    Meet Dr. Hirva Mamdani - Thoracic Oncology

    Hirva Mamdani, M.D., is the leader of the Thoracic Oncology Multidisciplinary Team at Karmanos Cancer Institute. She is also a member of the Phase I Clinical-Pharmacology Program, as well as Director of the Lung Cancer Screening Program at Karmanos.